Avenue Therapeutics, Inc.
ATXI
$0.28
-$0.03-8.35%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 1.40M | 1.40M | 1.40M | 1.40M | -- |
| Total Revenue | 1.40M | 1.40M | 1.40M | 1.40M | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.40M | 1.40M | 1.40M | 1.40M | -- |
| SG&A Expenses | 2.67M | 3.65M | 3.99M | 4.27M | 4.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.50M | 4.69M | 5.33M | 7.76M | 9.48M |
| Operating Income | -2.10M | -3.29M | -3.93M | -6.36M | -9.48M |
| Income Before Tax | -1.78M | -2.95M | -3.78M | -6.18M | -9.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.78 | -2.95 | -3.78 | -6.18 | -9.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 32.00K | 38.00K | 36.00K | 38.00K | 41.00K |
| Net Income | -1.75M | -2.91M | -3.74M | -6.14M | -9.16M |
| EBIT | -2.10M | -3.29M | -3.93M | -6.36M | -9.48M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.54 | -0.96 | -1.55 | -3.26 | -1.91 |
| Normalized Basic EPS | -0.38 | -0.63 | -0.96 | -2.03 | -3.60 |
| EPS Diluted | -0.54 | -0.96 | -1.55 | -3.26 | -1.91 |
| Normalized Diluted EPS | -0.38 | -0.63 | -0.96 | -2.03 | -3.60 |
| Average Basic Shares Outstanding | 12.85M | 12.52M | 11.23M | 9.65M | 7.58M |
| Average Diluted Shares Outstanding | 12.85M | 12.52M | 11.23M | 9.65M | 7.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |